An assessment of the immunosuppressive activity of the anti-tumour compound--4'-((9-acridinyl)amino)methanesulphon-m-anisidide (m-AMSA).
D000166:Acridines / Q000494:pharmacology*; D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects; D000951:Antigens, Neoplasm / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001402:B-Lymphocytes; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000494:pharmacology; D004912:Erythrocytes; D005260:Female; D006462:Hemolytic Plaque Technique; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008808:Mice, Inbred CBA; D008811:Mice, Inbred DBA; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology; D010655:Phenylenediamines / Q000494:pharmacology; D012756:Sheep; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013450:Sulfones / Q000494:pharmacology
D000166:Acridines; D000840:Anisoles; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D010655:Phenylenediamines; D013450:Sulfones; D003520:Cyclophosphamide